(Reuters) – A highly anticipated new immunotherapy from Merck Co Inc proved effective in patients with advanced melanoma as well as some with lung cancer or head and neck cancer, according to early-stage studies presented on Monday. Merck filed in January for U.S. Food and Drug…
Source:Merck immune system-booster effective in skin, lung cancer
Monday, June 2, 2014
Merck immune system-booster effective in skin, lung cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment